Chan JF, Li KS, To KK, Cheng VC, Chen H, Yuen KY: Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J Infect 2012, 65: 477-489. 10.1016/j.jinf.2012.10.002
Article
PubMed
Google Scholar
Zaki AM, Van BS, Bestebroer TM, Osterhaus AD, Fouchier RA: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012, 367: 1814-1820. 10.1056/NEJMoa1211721
Article
PubMed
CAS
Google Scholar
Pollack MP, Pringle C, Madoff LC, Memish ZA: Latest outbreak news from ProMED-mail: Novel coronavirus - Middle East. Int J Infect Dis 2013, 17: e143-e144. 10.1016/j.ijid.2012.12.001
Article
PubMed
Google Scholar
Memish ZA, Zumla AI, Al-Hakeem RF, Al-Rabeeah AA, Stephens GM: Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 2013, 368: 2487-2494. 10.1056/NEJMoa1303729
Article
PubMed
CAS
Google Scholar
Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S: The spike protein of SARS-CoV–a target for vaccine and therapeutic development. Nat Rev Microbiol 2009, 7: 226-236. 10.1038/nrmicro2090
Article
PubMed
CAS
PubMed Central
Google Scholar
Van BS, De GM, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus AD, Haagmans BL, Gorbalenya AE, Snijder EJ, Fouchier RA: Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 2012, 3: e00473-e00412.
Google Scholar
Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M: Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003, 426: 450-454. 10.1038/nature02145
Article
PubMed
CAS
Google Scholar
Raj VS, Mou H, Smits SL, Dekkers DH, Muller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA, Thiel V, Drosten C, Rottier PJ, Osterhaus AD, Bosch BJ, Haagmans BL: Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 2013, 495: 251-254. 10.1038/nature12005
Article
PubMed
CAS
Google Scholar
Gierer S, Bertram S, Kaup F, Wrensch F, Heurich A, Kramer-Kuhl A, Welsch K, Winkler M, Meyer B, Drosten C, Dittmer U, Von HT, Simmons G, Hofmann H, Pohlmann S: The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol 2013, 87: 5502-5511. 10.1128/JVI.00128-13
Article
PubMed
CAS
PubMed Central
Google Scholar
Du L, Zhao G, Zhang X, Liu Z, Yu H, Zheng BJ, Zhou Y, Jiang S: Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies. Biochem Biophys Res Commun 2010, 397: 580-585. 10.1016/j.bbrc.2010.05.161
Article
PubMed
CAS
Google Scholar
Du L, Zhao G, Kou Z, Ma C, Sun S, Poon VK, Lu L, Wang L, Debnath AK, Zheng BJ, Zhou Y, Jiang S: Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development. J Virol 2013, 87: 9939-9942. 10.1128/JVI.01048-13
Article
PubMed
CAS
PubMed Central
Google Scholar
Debnath AK, Radigan L, Jiang S: Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1. J Med Chem 1999, 42: 3203-3209. 10.1021/jm990154t
Article
PubMed
CAS
Google Scholar
Wang H, Qi Z, Guo A, Mao Q, Lu H, An X, Xia C, Li X, Debnath AK, Wu S, Liu S, Jiang S: ADS-J1 inhibits human immunodeficiency virus type 1 entry by interacting with the gp41 pocket region and blocking fusion-active gp41 core formation. Antimicrob Agents Chemother 2009, 53: 4987-4998. 10.1128/AAC.00670-09
Article
PubMed
CAS
PubMed Central
Google Scholar
Li L, Qiu J, Lu L, An S, Qiao P, Jiang S, Liu S: 3-Hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate inhibits HIV infection by blocking viral entry. J Antimicrob Chemother 2013, 68: 573-576. 10.1093/jac/dks458
Article
PubMed
CAS
Google Scholar
Liu S, Jing W, Cheung B, Lu H, Sun J, Yan X, Niu J, Farmar J, Wu S, Jiang S: HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides. J Biol Chem 2007, 282: 9612-9620. 10.1074/jbc.M609148200
Article
PubMed
CAS
Google Scholar
Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM: Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors. J Cell Biochem 2008, 104: 2335-2347. 10.1002/jcb.21790
Article
PubMed
CAS
Google Scholar
Lu L, Yang X, Li Y, Jiang S: Chemically modified bovine beta-lactoglobulin inhibits human papillomavirus infection. Microbes Infect 2013, 15: 506-510. 10.1016/j.micinf.2013.03.003
Article
PubMed
CAS
Google Scholar
Fuk-Woo CJ, Chan KH, Choi GK, To KK, Tse H, Cai JP, Yeung ML, Cheng VC, Chen H, Che XY, Lau SK, Woo PC, Yuen KY: Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis 2013, 207: 1743-1752. 10.1093/infdis/jit123
Article
Google Scholar
Jeffers SA, Tusell SM, Gillim-Ross L, Hemmila EM, Achenbach JE, Babcock GJ, Thomas WD Jr, Thackray LB, Young MD, Mason RJ, Ambrosino DM, Wentworth DE, Demartini JC, Holmes KV: CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci USA 2004, 101: 15748-15753. 10.1073/pnas.0403812101
Article
PubMed
CAS
PubMed Central
Google Scholar
Yang ZY, Huang Y, Ganesh L, Leung K, Kong WP, Schwartz O, Subbarao K, Nabel GJ: pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol 2004, 78: 5642-5650. 10.1128/JVI.78.11.5642-5650.2004
Article
PubMed
CAS
PubMed Central
Google Scholar
Faber M, Lamirande EW, Roberts A, Rice AB, Koprowski H, Dietzschold B, Schnell MJ: A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies. J Gen Virol 2005, 86: 1435-1440. 10.1099/vir.0.80844-0
Article
PubMed
CAS
PubMed Central
Google Scholar
Pang H, Liu Y, Han X, Xu Y, Jiang F, Wu D, Kong X, Bartlam M, Rao Z: Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine. J Gen Virol 2004, 85: 3109-3113. 10.1099/vir.0.80111-0
Article
PubMed
CAS
Google Scholar
Temperton NJ, Chan PK, Simmons G, Zambon MC, Tedder RS, Takeuchi Y, Weiss RA: Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis 2005, 11: 411-416. 10.3201/eid1103.040906
Article
PubMed
PubMed Central
Google Scholar
Mou H, Raj VS, Van Kuppeveld FJ, Rottier PJ, Haagmans BL, Bosch BJ: The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J Virol 2013, 87: 9379-9383. 10.1128/JVI.01277-13
Article
PubMed
CAS
PubMed Central
Google Scholar
Du L, Zhao G, Sun S, Zhang X, Zhou X, Guo Y, Li Y, Zhou Y, Jiang S: A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection. PLoS One 2013, 8: e53568. 10.1371/journal.pone.0053568
Article
PubMed
CAS
PubMed Central
Google Scholar
Du L, Zhao G, Li L, He Y, Zhou Y, Zheng BJ, Jiang S: Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells. Biochem Biophys Res Commun 2009, 384: 486-490. 10.1016/j.bbrc.2009.05.003
Article
PubMed
CAS
PubMed Central
Google Scholar
Du L, Zhao G, Lin Y, Sui H, Chan C, Ma S, He Y, Jiang S, Wu C, Yuen KY, Jin DY, Zhou Y, Zheng BJ: Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection. J Immunol 2008, 180: 948-956.
Article
PubMed
CAS
PubMed Central
Google Scholar
Du L, Zhao G, Chan CC, Sun S, Chen M, Liu Z, Guo H, He Y, Zhou Y, Zheng BJ, Jiang S: Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity. Virology 2009, 393: 144-150. 10.1016/j.virol.2009.07.018
Article
PubMed
CAS
PubMed Central
Google Scholar
Li L, Qiao P, Yang J, Lu L, Tan S, Lu H, Zhang X, Chen X, Wu S, Jiang S, Liu S: Maleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission. Retrovirology 2010, 7: 37. 10.1186/1742-4690-7-37
Article
PubMed
CAS
PubMed Central
Google Scholar